Skip to search formSkip to main contentSkip to account menu

Rhodotorula mucilaginosa extract 50 MG/ML Injectable Solution

Known as: RHODOTORULA MUCILAGINOSA 1 g in 20 mL SUBCUTANEOUS INJECTION, SOLUTION [RHODOTORULA MUCILAGINOSA], RHODOTORULA MUCILAGINOSA 1 g in 20 mL PERCUTANEOUS INJECTION, SOLUTION [RHODOTORULA MUCILAGINOSA], Rhodotorula mucilaginosa extract 0.05 GM/ML Injectable Solution 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The highest number (35.1% of global incident cases) of new oropharyngeal (OP) and hypopharyngeal (HP) cancer cases was reported… 
2019
2019
Rothia mucilaginosa is part of the oral and upper respiratory tract flora. Usually, this gram‐positive coccus is not pathogenic… 
2018
2018
Abstract Invertases are used for several purposes; one among these is the production of fructooligosaccharides. The aim of this… 
2017
2017
Rothia mucilaginosa, previously known as Stomatococcus mucilaginosus, is a Gram-positive coccus that is part of the oropharyngeal… 
2013
2013
This paper presents a rare case of facial soft tissue infection caused by the bacterial strain of Rothia mucilaginosa… 
2010
2010
Rothia mucilaginosa is an opportunistic pathogen in the human oral cavity and pharynx. We found that R. mucilaginosa DY-18, a… 
2010
2010
Infections with rare pathogens are being recognized with increasing frequency in severely immunocompromised patients. As a result… 
Review
2009
Review
2009
Rothia mucilaginosa is a Gram-positive, coagulase-negative, encapsulated, non-spore-forming coccus considered part of the… 
2007
2007
Rothia mucilaginosa, previously known as Stomatococcus mucilaginosus, is a Gram-positive microrganism, which is a part of normal…